Study of Sexual Well-being in Adults With Gynecologic Cancer and Their Partners Over Time

What this Trial Is About

This observational, exploratory, prospective, longitudinal, multicenter study aims to track changes in sexual function over time in patients diagnosed with gynecologic cancers and their partners, without altering their standard clinical care. The study focuses on understanding how sexual health and relationships are affected by these cancers, addressing a frequently overlooked aspect of patient well-being recognized by the World Health Organization as a fundamental right. It seeks to evaluate sexual function questionnaire scores and the perceived usefulness and timing of sexual counseling support. Participants include patients with various gynecological cancers and their partners. Patients complete the Female Sexual Function Index FSFI questionnaire and a detailed section on sexual experience, satisfaction, and difficulties. Male partners complete the International Index of Erectile Function IIEF-15, while female partners complete the same assessments as patients. Questionnaires are administered at diagnosis T0, six months after treatment starts T1, and twelve months after treatment or surgery completion T2. Sociodemographic, clinical, lifestyle, and relationship data are also collected. During the study, participants provide written informed consent and complete questionnaires at three key time points. Data are recorded with pseudonymized codes to protect privacy. Researchers will analyze changes in FSFI and IIEF-15 scores over time and assess how many participants find sexual counseling helpful and when they prefer it. The study expects to enroll 200 patients and 200 partners, with data collection and analysis continuing through follow-up visits over approximately a year after treatment.

Assessment of Sexual Well-being in Patients With Gynecologic Cancer and Their Partners: the ONCOSEX Study